Hoechst Pakistan (KAR:HPL) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 26, 2026)


KAR:HPL Hoechst Pakistan Ltd KAR:HPL
86 GF Score
Price ₨4,015.00
GF Value ₨3,253.76
Valuation Modestly Overvalued
! 1 Warning Sign
View Full Analysis

What is Hoechst Pakistan Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Hoechst Pakistan's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

KAR:HPL vs LLY, JNJ, ABBV: Margin of Safety % (DCF FCF Based) Comparison

For the Drug Manufacturers - General subindustry, Hoechst Pakistan's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hoechst Pakistan Margin of Safety % (DCF FCF Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hoechst Pakistan's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Hoechst Pakistan's Margin of Safety % (DCF FCF Based) falls into.


KAR:HPL
86GF Score
Hoechst Pakistan Ltd KAR:HPL
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Hoechst Pakistan (KAR:HPL) Overvalued in 2026?

Based on GuruFocus' analysis, Hoechst Pakistan stock appears to be overvalued. The current stock price of ₨4,015.00 is trading 23.4% above its estimated GF Value™ of ₨3,253.76. GuruFocus considers Hoechst Pakistan to be Modestly Overvalued.

Key valuation signals for KAR:HPL:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: ₨3,253.76 vs. price of ₨4,015.00 (23.4% above fair value)
  • GF Score™: 86/100 with 1 warning sign

No single metric tells the full story. See the KAR:HPL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hoechst Pakistan Business Description

Address Plot 23, Sector 22, Korangi Industrial Area, Karachi, PAK, 74900
Hoechst Pakistan Ltd is a healthcare company of Pakistan, focused on patient needs and engaged in the manufacturing, promotion, and sale of pharmaceutical and vaccines. The company engages in the manufacturing, selling and trading of pharmaceutical and related products.
86GF Score

Get the complete analysis for KAR:HPL

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₨4,015.00
Price
₨3,253.76
GF Value